ED2-21905-94027
5 vaccinations
10 coded responses
63 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-26
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Dose 1 — Pfizer-BioNTech
-
2021-04-26
Registered in v-safe
- 2021-04-26
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 1MedDRA: Poor quality sleep — Feeling: GoodFree text: Not sleeping great.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
-
2021-04-30
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
-
2021-05-14
Dose 2 — Pfizer-BioNTech
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
- 2021-11-12
-
2021-11-16
Dose 3 — Moderna
- 2021-11-17
-
2021-11-18
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: A bruise is at the injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising, Injection site discolouration — Feeling: Good · Site: PainFree text: Dark-purple colored bruise at the injection site continues.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: The dark-purple bruise remains present at the injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising, Injection site discolouration — Feeling: Good · Site: PainFree text: Dark-purple bruise at the injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruise at injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Survey response — day 7, dose 3MedDRA: Injection site bruising, Injection site discolouration — Feeling: Good · Site: PainFree text: Purple Bruise at injection site.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-02-15
-
2022-05-17
Dose 4 — Moderna
- 2022-05-17
- 2022-05-17
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-21
- 2022-05-22
- 2022-05-23
- 2022-05-24
-
2022-05-31
Survey response — day 14, dose 4MedDRA: Back pain — Feeling: FairFree text: Lower back pain, left side. It First appeared for a day or so after the 2nd booster shot. It arose shortly after I had completed the v-safe symptom checker after the 2nd booster.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
-
2022-08-16
Survey response — 3 months, dose 4MedDRA: Norovirus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Brief norovirus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Dose 5 — Moderna
-
2022-10-21
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2023-01-19
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Moderna | No |
| 4 | 2022-05-17 | Moderna | No |
| 5 | 2022-10-20 | Moderna | No |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Not sleeping great.
Release 8 — day 7, dose 1
Systemic reaction (other): No
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): A bruise is at the injection site.
Systemic reaction (other): Dark-purple colored bruise at the injection site continues.
Systemic reaction (other): The dark-purple bruise remains present at the injection site.
Systemic reaction (other): Dark-purple bruise at the injection site.
Systemic reaction (other): Bruise at injection site.
Release 10 — day 7, dose 3
Systemic reaction (other): Purple Bruise at injection site.
Release 11 — day 14, dose 4
Symptoms: Lower back pain, left side. It First appeared for a day or so after the 2nd booster shot. It arose shortly after I had completed the v-safe symptom checker after the 2nd booster.
Release 12 — 3 months, dose 4
Symptoms: Brief norovirus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Poor quality sleep | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release